World Orphan Drug Congress USA 2019
April 10, 2019 ‐ April 12, 2019 in Oxon Hill, Maryland (USA)
The World Orphan Drug Congress USA 2019 will be held from April 10 to 12, 2019 in Oxon Hill, Maryland.
André Choulika, Ph.D., Chairman and Chief Executive Officer of Cellectis, will participate in this event as part of the Keynote Panel on Thursday, April 11 at 9:40 AM EST to discuss "Advancing cell and gene therapy – considerations in manufacturing, R&D expertise, early payer engagement and continuous patient centricity"
David Sourdive, Ph.D., Executive Vice President, Technical Operations, will also participate in this event on April the 11th from 12:15 PM to 12:40 PM EST with a presentation entitled "How Cellectis evolves its gene-editing enabled off-the-shelf CAR-T manufacturing to meet cell therapy commercial standards"